At BrainZell, we specialize in generating high-throughput brain organoids derived from induced pluripotent stem cells (iPSCs). Our innovative platform closely mimics human neural biology, utilizing an automated process with rigorous quality checks at every stage.
Why BrainZell?
From neural activity testing and toxicity assessment to phenotypic assays, our technology empowers well-informed decisions on the efficacy and safety of compounds and biologics.
Datapoints
News















